Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort. - Wikidata - wikimedia - TriplyDB

Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.

Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.

http://www.wikidata.org/entity/Q33529416

about

Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.Perioperative management of drugs commonly used in patients with rheumatic diseases: a review Systemic lupus erythematosus: review of synthetic drugs.The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicine Taxonomy for systemic lupus erythematosus with onset before adulthood Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study.Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.Systemic lupus erythematosus in Hispanics.The role of antimalarial agents in the treatment of SLE and lupus nephritis.Utilizing registries in systemic lupus erythematosus clinical research.New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.International consensus for provisions of quality-driven care in childhood-onset systemic lupus erythematosus.Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand?Treatment of severe lupus nephritis: the new horizon.A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.Lupus in Latin-American patients: lessons from the GLADEL cohort.Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood.Long-term Outcome of Lupus Nephritis Class II in Argentine Patients: An Open Retrospective Analysis.Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels.Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus.Systemic lupus erythematous and clinical outcomes in peritoneal dialysis.Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double-Blind, Randomized, Parallel-Group Trial.Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect.Dyslipidaemia in patients with lupus nephritis.Complement levels and risk of organ involvement in patients with systemic lupus erythematosus.Antiphospholipid antibodies, steroid dose, arterial hypertension, relapses, and late-onset predict organ damage in a population of Colombian patients with systemic lupus erythematosus.Antimalarial-induced cardiomyopathy: a systematic review of the literature.Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.Treatment Algorithms for Patients with Systemic Lupus Erythematosus: Comment on the Article by Muangchan et al.Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment.A study of Thai patients with systemic lupus erythematosus in the medical intensive care unit: epidemiology and predictors of mortality.Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus.Systemic lupus erythematosus risk factors for coronary artery calcifications.Epidemiology of systemic lupus erythematosus.

P2860

Q33422958-1CA45245-6485-4667-B937-F718B7DE4471 Q33775870-5BBEB1BE-B39A-4F4F-ABE5-2D6AC060D652 Q34498515-51F79EF4-1E9B-4896-B983-C0DB9CDD45FE Q35169351-ED367D9F-6A1C-4C8C-9F4E-67D9E3F1B412 Q36088877-9C655C31-CFA3-459C-8533-190271F17DF4 Q36295937-6292C1F4-EBE0-402A-BEDC-70419907C43F Q36307429-C4139BCF-9E3D-4405-89F7-1326153A81D8 Q36606667-65CEFE05-0DE6-4C70-B8FE-9B322D338121 Q37330468-CC66D602-0BB6-43C1-8426-DFA0F7126B1F Q37921757-AF86BF31-6F71-429B-8E13-0EBD967C0A5C Q37947108-73C9B5C3-7A36-4BF9-BD3C-11155B877524 Q38011226-0DF2CA39-D4D1-4C82-B23A-D0EB48B525F7 Q38026787-3276779F-1D90-4C17-90F9-F72E70500EF6 Q38029146-C232EC1A-AA58-48D2-A199-5389E51D4B9B Q38086806-D7C3374A-467B-4FAD-99C8-37E2488AE62A Q38149850-260018CB-4620-43EC-AE6C-E0C2AA26141F Q38271125-9A5D3644-0F2B-4CB9-A7EF-38993D74ABDB Q38352048-C01A310B-E029-4C0E-AFDB-A6F8034F0411 Q38362113-64719897-DA43-42C4-AB6A-7A81752A5435 Q38600390-9C45F72B-4612-4B41-B1E1-3E62A739CC31 Q38776952-7442CDE6-7E12-4FAD-A6B0-D83E37DF94B9 Q39789199-A09B2FFD-D922-4E96-A05E-A0BE5DA2F12D Q39997361-16CA1FB9-8CBE-435C-B9F3-712CCE9E08CF Q40156825-C7792008-4449-4884-B6E7-3C8FB0514552 Q41680597-1E8AEF95-90D0-459E-9E27-B926FE4E8C72 Q41701045-DEC3D8D7-3354-4987-B165-2F762A5355DF Q41913718-6BB4C5EB-BB9B-46A6-BEFE-E1AFC93DCD05 Q41927831-34D65E35-996D-48BE-B51A-2597EDB849B5 Q41929433-8E1B85F7-8B5B-4560-BD47-10E1E06794E9 Q44220064-AAC7D6FC-174B-4BF4-AB46-FC802CCBACC8 Q47096234-5BBCC911-D762-458F-9108-36CBD9BAD4E4 Q48182257-04261598-AF36-4753-9DC9-D4F949475797 Q49383501-D0B891B7-3A1F-4BA2-BB22-AE8C5900E8F8 Q50222848-02E185ED-FDA6-4E00-855A-510E195245ED Q50726116-B97D0E8E-C623-4B07-901B-791409CD234E Q51000181-0C233579-FA91-4D24-B012-2121EEF109DA Q51702281-673AB41F-D358-4930-9CB9-202DAD309B5E Q52316454-3DE28089-4982-40F4-B7A5-BBF07540CD98 Q53194239-1A328FAE-0EB1-4ACC-A2AC-EC76E38B8198 Q53839415-CAEA8314-9A6F-4E49-A570-B62DF3A79BD8

P2860

Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.

http://www.wikidata.org/entity/Q33529416

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Antimalarial treatment may hav ...... tin American inception cohort.

@ast

Antimalarial treatment may hav ...... tin American inception cohort.

@en

Antimalarial treatment may hav ...... tin American inception cohort.

@nl

type

label

Antimalarial treatment may hav ...... tin American inception cohort.

@ast

Antimalarial treatment may hav ...... tin American inception cohort.

@en

Antimalarial treatment may hav ...... tin American inception cohort.

@nl

prefLabel

Antimalarial treatment may hav ...... tin American inception cohort.

@ast

Antimalarial treatment may hav ...... tin American inception cohort.

@en

Antimalarial treatment may hav ...... tin American inception cohort.

@nl

P1433

Q33529416-C5119233-81DE-4D5D-BCB3-E2DE2A304CD0

P1476

Q33529416-9147270B-6084-4B88-9739-81AD9DCBF7D5

P2093

Q33529416-1604ACCD-C9F5-4AF6-A2A8-A92DF90358E3

Q33529416-353A8C49-2231-4D30-A250-1B2E2752F7BE

Q33529416-37E94DB8-1800-4AE3-814A-1F3F56F22970

Q33529416-3AF3DA1A-4A6F-49B9-8A94-6286D5FA9DEF

Q33529416-50A4C72D-CAF2-472E-8420-A3C63150687B

Q33529416-6F3E3BF4-B80E-4353-86FB-6FF13344FA14

Q33529416-7835E0B5-7DE8-4182-953A-E3474E76D5AC

Q33529416-8558AF72-6694-4E5B-82C9-9DAA03CDB99A

Q33529416-8E9C1F20-AE15-4B15-87E1-64E88D03E2D9

Q33529416-94B94B30-FFED-47DD-8FBE-D3D544E65C0C

P2860

Q33529416-47A35AEF-4B43-4BC2-A7BC-9A2BEDE34D7C

Q33529416-98689534-D0B1-44F6-BF18-C3AF6990F43F

Q33529416-EC2EFDA6-4C4E-4E3D-B1A6-D0A4D4C82816

P304

Q33529416-6F5DB702-4560-4AD2-BDE4-47B3F50693BE

P31

Q33529416-0A3D7E5C-D9E4-483C-827B-634E084076EF

P356

Q33529416-E5CF755E-F400-445F-8E87-7B1B32DF3F6B

P433

Q33529416-5DD5B01A-A5B8-4062-8381-5CC0514040F7

P478

Q33529416-D34389AB-AC3A-447D-9BF0-CC86B492D368

P50

Q33529416-441B0CF9-76E8-4F34-8C62-9E5ECB984586

Q33529416-A62A67BC-EEAC-47AE-B6A6-E1B587BAE1F9

Q33529416-C30806A2-C7C6-42CA-B6C1-A39D1C445477

Q33529416-F8ABCA27-E20B-409C-931F-2CD567301768

P577

Q33529416-A21BB8D7-EF67-4CE4-A5E0-AD13E5F47049

P5875

Q33529416-74328D79-54AA-43A9-A1DC-CE02679DC47A

P698

Q33529416-042EB0A6-A25C-4379-9876-1928182CCC5C

P921

Q33529416-4290200B-7BA9-4089-9C7C-FC18E6C32D20

P356

P1433

Arthritis and Rheumatism

P1476

Antimalarial treatment may hav ...... atin American inception cohort

@en

P2093

Bernardo A Pons-Estel

http://www.w3.org/2001/XMLSchema#string

Daniel Wojdyla

http://www.w3.org/2001/XMLSchema#string

Eduardo M Acevedo-Vázquez

http://www.w3.org/2001/XMLSchema#string

Francisco Caeiro

http://www.w3.org/2001/XMLSchema#string

Graciela S Alarcón

http://www.w3.org/2001/XMLSchema#string

Grupo Latino Americano de Estudio del Lupus Eritematoso (Gladel)

http://www.w3.org/2001/XMLSchema#string

Guillermo A Berbotto

http://www.w3.org/2001/XMLSchema#string

Hugo R Scherbarth

http://www.w3.org/2001/XMLSchema#string

Ignacio Garcia De La Torre

http://www.w3.org/2001/XMLSchema#string

João C Tavares Brenol

http://www.w3.org/2001/XMLSchema#string

P2860

Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice.

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.

Vascular stiffness in women with systemic lupus erythematosus.

P304

855-862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.27300

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo F Borba

Samuel Katsuyuki Shinjo

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41406116

http://www.w3.org/2001/XMLSchema#string

P698

20131238

http://www.w3.org/2001/XMLSchema#string

P921